CRP and COVID-19: Added to that, the CRP level has also been reported as a reliable biomarker for treatment responses in COVID-19 patients19; in fact, this marker could be used to select patients who would benefit from treatment with tocilizumab, another IL-6 receptor inhibitor similar to sarilumab.54,55